You are here

Várkonyi István Zsolt

Várkonyi István Zsolt

Várkonyi István Zsolt
DE > ÁOK
tanszékvezető c. egyetemi docens 2017-
Name: Várkonyi István Zsolt
Other profiles: Google Scholar, MTMT
Degree
  • PhD, Semmelweis Egyetem (2015)
  • c. egyetemi docens, Semmelweis Egyetem (2024)
Consulting hours:
péntek 10:00 - 11:00

Publication list

Uploaded publications:
25
Publications in DEA:
25
OA:
7
Date range:
2010-2022
2022
2021
  1. Nagy, B., Fejes, Z., Szentkereszty, Z., Sütő, R., Várkonyi, I., Ajzner, É., Kappelmayer, J., Papp, Z., Tóth, A., Fagyas, M.: A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient.
    Int. J. Infect. Dis. 103 412-414, 2021.
    Journal metrics:
    D1 Infectious Diseases
    D1 Medicine (miscellaneous)
    D1 Microbiology (medical)
  2. Szekanecz, Z., Bogos, K., Constantin, T., Fülesdi, B., Müller, V., Rákóczi, É., Várkonyi, I., Vályi-Nagy, I.: Antivirális és gyulladásellenes kezelési lehetőségek COVID-19-ben.
    Orv. hetil. 162 (17), 643-651, 2021.
    Journal metrics:
    Q4 Medicine (miscellaneous)
  3. Szekanecz, Z., Bogos, K., Constantin, T., Fülesdi, B., Müller, V., Rákóczi, É., Várkonyi, I., Vályi-Nagy, I.: Gyógyszeres terápiás javaslat COVID-19-ben.
    Gyermekgyógy. Továbbk. Szle. 24 (3), 67-74, 2021.
2020
  1. Szekanecz, Z., Bálint, P., Balog, A., Barta, Z., Czirják, L., Géher, P., Kovács, L., Kumánovics, G., Nagy, G., Rákóczi, É., Szamosi, S., Szűcs, G., Vályi-Nagy, I., Várkonyi, I., Constantin, T.: COVID-19: a citokinviharon innen és túl....
    Immunol. Szle. 12 (4), 4-14, 2020.
  2. Merkely, B., Szabó, A., Kosztin, A., Berényi, E., Sebestyén, A., Lengyel, C., Merkely, G., Karády, J., Várkonyi, I., Papp, C., Miseta, A., Betlehem, J., Burián, K., Csóka, I., Vásárhelyi, B., Ludwig, E., Prinz, G., Sinkó, J., Hankó, B., Varga, P., Fülöp, G., Mag, K., Vokó, Z., HUNgarian COronaVirus-19 Epidemiological Research (H-UNCOVER) investigators: Novel coronavirus epidemic in the Hungarian population, a cross-sectional nationwide survey to support the exit policy in Hungary.
    GeroScience. 42 (4), 1063-1074, 2020.
    Journal metrics:
    Q1 Aging
    Q1 Cardiology and Cardiovascular Medicine
    D1 Complementary and Alternative Medicine
    D1 Geriatrics and Gerontology
    D1 Veterinary (miscellaneous)
2017
  1. Orlos, Z., Rákóczi, É., Misák, O., Lénárt, B., Ócsai, G., Kovács, I., Gorzsás, S., Kardos, L., Lampé, Z., Szilvássy, Z., Várkonyi, I.: Outbreak of anthrax in adults and adolescents: a review of nine cases in a regional teaching hospital in East Hungary.
    Clin. Microbiol. Infect. 23 (1), 52-54, 2017.
    Journal metrics:
    D1 Infectious Diseases
    D1 Medicine (miscellaneous)
    D1 Microbiology (medical)
2016
  1. Foster, G., Coppola, C., Derbala, M., Ferenci, P., Orlandini, A., Reddy, K., Tallarico, L., Shiffman, M., Ahlers, S., Bakalos, G., Hassanein, T., GUARD-C Study Group: Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: results from the GUARD-C Cohort.
    PLoS One. 11 (3), e0151703, 2016.
  2. Kirsner, R., Vanscheidt, W., Keast, D., Lantis, J., Dove, C., Cazzell, S., Vartivarian, M., Augustin, M., Marston, W., McCoy, N., Cargill, D., Lee, T., Dickerson, J., Slade, H., HP802-247 Study Group: Phase 3 evaluation of HP802-247 in the treatment of chronic venous leg ulcers.
    Wound Repair Regen. 24 (5), 894-903, 2016.
  3. Novák, Z., Yanez, A., Kiss, I., Kuna, P., Tortajada-Girbes, M., Valiente, R., Bilastine Paediatric Safety Study Group: Safety and tolerability of bilastine 10 mg administered for 12 weeks in children with allergic diseases.
    Pediatr. Allergy Immunol. 27 (5), 493-498, 2016.
2015
  1. Várkonyi, I., Chappey, C., Giraudon, M., Burleigh, L.: A part-randomized study of intravenous oseltamivir in adolescents and adults.
    Eur. J. Clin. Microbiol. Infect. Dis. 34 (6), 1181-1188, 2015.
    Journal metrics:
    Q2 Infectious Diseases
    Q1 Medicine (miscellaneous)
    Q2 Microbiology (medical)
  2. Gergely, Z., Rákóczi, É., Várkonyi, I.: Pneumonia - és melyik antibiotikum?.
    Granum. 18 (3), 18-20, 2015.
2014
  1. Várkonyi, I., Rákóczi, É., Misák, O., Komáromi, E., Kardos, L., Lampé, Z., Szilvássy, Z.: Findings of a hospital surveillance-based outcome evaluation study for Clostridium difficile-associated colitis.
    Clin. Microbiol. Infect. 20 (10), 1085-1090, 2014.
    Journal metrics:
    D1 Infectious Diseases
    D1 Medicine (miscellaneous)
    D1 Microbiology (medical)
2013
2012
  1. de Bruijne, J., van Vliet, A., Weegink, C., Mazur, W., Wiercinska-Drapalo, A., Simon, K., Cholewinska-Szymanska, G., Kapocsi, J., Várkonyi, I., Zhou, X., Temam, M., Molles, J., Chen, J., Pietropaolo, K., McCarville, J., Sullivan-Bolyai, J., Mayers, D., Reesink, H.: Rapid decline of viral RNA in chronic hepatitis C patients treated once daily with IDX320: a novel macrocyclic HCV protease inhibitor.
    Antivir. Ther. 17 (4), 633-642, 2012.
    Journal metrics:
    Q1 Infectious Diseases
    Q1 Pharmacology
    Q1 Pharmacology (medical)
2011
  1. Várkonyi, I., Makai, I., Papdiné Nyíri, G., Bacskó, G., Kardos, L.: A császármetszés posztoperatív sebfertőzés surveillance tapasztalatai a debreceni Kenézy Kórházban.
    Orvosi Hetilap. 152 (1), 14-22, 2011.
    Journal metrics:
    Q3 Medicine (miscellaneous)
  2. Guyader, D., Bogomolov, P., Kobalava, Z., Moiseev, V., Szlávik, J., Astruc, B., Várkonyi, I., Sullivan, T., Horgan, K., Bexon, A., Arbeit, R.: Imo-2125 plus ribavirin gives substantial first-dose viral load reductions, cumulative anti-viral effect, is well tolerated in naive genotype1 hcv patients: a phase 1 trial.
    J. Hepatol. 54 S478-, 2011.
2010
  1. Calverley, P., Rabe, K., Goehring, U., Kristiansen, S., Fabbri, L., Martinez, F., M2-124 and M2-125 study groups: Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials.
    Lancet. 374 (9691), 685-694, 2010.
updated: 2024-10-06, 01:30

SCImago quartiles of
scientific journal articles

Number of scientific articles: 16
Q1/D1 4 (25%)
Q1 6 (37.5%)
Q2 1 (6.3%)
Q3 1 (6.3%)
Q4 1 (6.3%)
N/A 7 (43.8%)
-
OK

SCImago subject areas and categories

Medicine (8)
Medicine (miscellaneous) (6)
Infectious Diseases (5)
Microbiology (medical) (4)
Cardiology and Cardiovascular Medicine (1)
Complementary and Alternative Medicine (1)
Geriatrics and Gerontology (1)
Pharmacology (medical) (1)
Biochemistry, Genetics and Molecular Biology (2)
Aging (1)
Clinical Biochemistry (1)
Pharmacology, Toxicology and Pharmaceutics (1)
Pharmacology (1)
Veterinary (1)
Veterinary (miscellaneous) (1)

Genre chart

Year chart

Language chart

Other co-authors

Show more
Calverley, Peter M. A.
Cholewinska-Szymanska, Grazyna
Goehring, Udo-Michael
Martinez, Fernando, J.
McCarville, Joseph F.
Orlandini, Alessandra
Papdiné Nyíri Gyöngyi
Shiffman, Mitchell L.
Sullivan-Bolyai, John Z.
Szentkereszty Zoltán
Temam, Marie-Francoise
Tortajada-Girbes, Miguel
Vanscheidt, Wolfgang
Weegink, Christine J.
Wiercinska-Drapalo, Alicja